Presentation Information
[O-38-6]Specificity evaluation of the features included in the international MOGAD panel proposed criteria
Naoki Yamamoto1, Yuki Matsumoto1, Yoshiki Takai1, Toshiyuki Takahashi2, Kimihiko Kaneko1, Mizuki Otomo1, Naohiro Sakamoto1, Naoya Yamazaki1, Shu Umezawa1, Chihiro Namatame1, Hirohiko Ono1, Shuhei Nishiyama1, Hiroshi Kuroda3,4, Kazuo Fujihara3,4, Tatsuro Misu1, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Neurology, National Hospital Organization Yonezawa National Hospital, Japan, 3.Multiple Sclerosis & Neuromyelitis Optica Center, Japan, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan)